Abstract
Surgeons are not supposed to make patients functionally or mentally worse after an operation. This becomes especially important in mesothelioma, where the role of a cytoreductive operation has come under question for its magnitude and, frankly, its efficacy. The article by Mollberg and colleagues [1] fills an important void in the management of pleural mesothelioma, which, frankly, is one among many elephants in the room regarding the changing views of surgical procedures in this disease. For patients with minimal symptoms who actually may have less than average bulky disease or fluid-dominant disease, pleurectomy decortication, either standard or as an extended operation, is now challenging extrapleural pneumonectomy as the standard for stage I and stage II mesothelioma in selected patients.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
